Skip to main content
GMAB logo

Genmab A/S

GMABNASDAQHealthcareBiotechnology

$37.00Today:- (-)1Y +14.02%

As of Oct 16, 2026 close

Market cap
$23.34B
P/E (TTM)
29.61
Forward P/E
36.72
Dividend yield
-
52-week range
$23.62$40.17
Volume (live)
-
Avg. volume (3M)
3.41M

Genmab A/S (GMAB) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Genmab A/S had a P/E ratio of 20.38 (up from 11.62), return on equity of 17.5% (down from 23.1%), debt-to-equity of 0.93 (up from 0.03) and a current ratio of 2.02 (down from 5.24). A current ratio of 2.02 means current assets exceed current liabilities.

Genmab A/S Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Jan 2024Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio20.3811.6233.0335.2658.1933.86
P/S Ratio5.284.228.7213.2520.4415.93
P/B Ratio3.362.564.457.057.758.43
Price/Tangible Book-4.314.467.087.848.58
Price/FCF17.0811.9820.4753.4787.0826.30
Price/OCF16.5511.6919.4649.1477.2325.04
Enterprise Value Ratios
EV/Revenue4.403.497.0611.6618.2714.24
EV/EBITDA12.6810.3621.0525.7948.8622.00
EV/EBIT13.0910.7321.8726.9852.0722.81
EV/FCF14.249.9116.5947.0377.8123.50
Profitability & Returns
Return on Equity (ROE)17.54%23.07%14.46%22.04%14.31%28.69%
Return on Assets (ROA)8.10%10.89%9.96%14.31%8.07%21.75%
Return on Invested Capital (ROIC)16.82%58.66%83.50%108.72%64.65%160.54%
Return on Capital Employed (ROCE)10.90%17.90%15.90%22.10%12.80%31.70%
Leverage & Solvency Ratios
Debt/Equity0.930.030.020.020.020.02
Debt/EBITDA4.150.140.140.090.140.05
Debt/FCF4.720.130.110.170.210.05
Liquidity Ratios
Current Ratio2.025.2413.3515.4814.5015.00
Quick Ratio2.015.2313.3315.4814.5015.00
Efficiency Ratios
Asset Turnover0.390.540.490.530.370.56
Inventory Turnover17.6316.82----
Yield & Distribution Ratios
Earnings Yield4.91%8.61%3.03%2.84%1.72%2.95%
FCF Yield5.85%8.35%4.89%1.87%1.15%3.80%
Buyback Yield3.04%1.88%0.17%0.06%-0.24%-3.53%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Genmab A/S Financial Ratios

What is Genmab A/S's P/E ratio?

Genmab A/S's P/E ratio was 20.38 for fiscal 2025 (period ended Dec 31, 2025). It was 11.62 a year earlier.

What is Genmab A/S's return on equity?

Genmab A/S's return on equity (ROE) was 17.5% for fiscal 2025 (period ended Dec 31, 2025). It was 23.1% a year earlier.

What is Genmab A/S's debt-to-equity ratio?

Genmab A/S's debt-to-equity ratio was 0.93 for fiscal 2025 (period ended Dec 31, 2025). It was 0.03 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition